Debt-to-equity of NEUROONE MEDICAL TECHNOLOGIES Corp from 31 Mar 2012 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 31 Dec 2025.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Debt-to-equity for the quarter ending 31 Dec 2025 was 52%, a 52% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 52% -57% -52% 31 Dec 2025
Q3 2025 69% -9% -12% 30 Sep 2025
Q2 2025 108% +70% +182% 30 Jun 2025
Q1 2025 169% +133% +370% 31 Mar 2025
Q4 2024 109% +75% +224% 31 Dec 2024
Q3 2024 78% +49% +171% 30 Sep 2024
Q2 2024 38% +8% +27% 30 Jun 2024
Q1 2024 36% +14% +66% 31 Mar 2024
Q4 2023 34% +18% +111% 31 Dec 2023
Q3 2023 29% +16% +122% 30 Sep 2023
Q2 2023 30% +20% +207% 30 Jun 2023
Q1 2023 22% +11% +112% 31 Mar 2023
Q4 2022 16% +5% +45% 31 Dec 2022
Q3 2022 13% -23% -64% 30 Sep 2022
Q2 2022 9.8% -39% -80% 30 Jun 2022
Q1 2022 10% -169% -94% 31 Mar 2022
Q4 2021 11% +440% 31 Dec 2021
Q3 2021 36% +250% 30 Sep 2021
Q2 2021 48% +209% 30 Jun 2021
Q1 2021 179% +333% 31 Mar 2021
Q4 2020 -429% -200% -87% 31 Dec 2020
Q3 2020 -214% -27% -15% 30 Sep 2020
Q2 2020 -160% -7% -4.6% 30 Jun 2020
Q1 2020 -154% -32% -26% 31 Mar 2020
Q4 2019 -229% -123% -117% 31 Dec 2019
Q3 2019 -187% -83% -79% 30 Sep 2019
Q2 2019 -153% -49% -47% 30 Jun 2019
Q1 2019 -122% -17% -16% 31 Mar 2019
Q4 2018 -106% +0.37% +0.35% 31 Dec 2018
Q3 2018 -104% +21% +17% 30 Sep 2018
Q2 2018 -104% +121% +54% 30 Jun 2018
Q1 2018 -105% +128% +55% 31 Mar 2018
Q4 2017 -106% +132% +56% 31 Dec 2017
Q3 2017 -125% -22% -21% 30 Sep 2017
Q2 2017 -226% -123% -120% 30 Jun 2017
Q1 2017 -233% -131% -130% 31 Mar 2017
Q4 2016 -238% -137% -135% 31 Dec 2016
Q3 2016 -103% -2.8% -2.8% 30 Sep 2016
Q2 2016 -102% -1.6% -1.6% 30 Jun 2016
Q1 2016 -101% -0.01% -0.01% 31 Mar 2016
Q4 2015 -101% +1.3% +1.2% 31 Dec 2015
Q3 2015 -101% +2.4% +2.4% 30 Sep 2015
Q2 2015 -101% +2% +1.9% 30 Jun 2015
Q1 2015 -101% +1.9% +1.9% 31 Mar 2015
Q4 2014 -102% +5.1% +4.7% 31 Dec 2014
Q3 2014 -103% +6.3% +5.8% 30 Sep 2014
Q2 2014 -103% +9.1% +8.1% 30 Jun 2014
Q1 2014 -103% +19% +15% 31 Mar 2014
Q4 2013 -107% +25% +19% 31 Dec 2013
Q3 2013 -109% +67% +38% 30 Sep 2013
Q2 2013 -112% +81% +42% 30 Jun 2013
Q1 2013 -122% +44% +27% 31 Mar 2013
Q4 2012 -132% 31 Dec 2012
Q3 2012 -176% 30 Sep 2012
Q2 2012 -193% 30 Jun 2012
Q1 2012 -167% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.